Disease | lupus erythematosus, systemic |
Symptom | C0162323|polyarthritis |
Sentences | 1 |
PubMedID- 19965944 | In conclusion, the addition of rituximab to conventional immunosuppressive therapy may be an effective strategy for lupus nephritis, autoimmune thrombocytopenia and inflammatory polyarthritis in patients with refractory systemic lupus erythematosus. |
Page: 1